title: [Prescriptions in patients with coronary artery disease].
abstract: The management of stable coronary artery disease has evolved in recent years and is now based on the latest recommendations of the European Society of Cardiology. Drug prescription takes into account two strategic approaches: on the one hand, pharmacological treatments that improve the prognosis and on the other hand treatments to improve symptoms and/or ischemia. Improving the prognosis involves reducing as well as stabilizing coronary plaque thanks to 3 therapeutic classes: aspirin, statins and renin-angiotensin system blockers (ACE inhibitors or ARBs). In parallel, a fast-acting nitrovasodilator associated with a beta-blocker or a heart-slowing calcium-channel blocker makes it possible to reduce the angina. In addition, pharmacological modifications and regular reassessments are fundamental aspects of CAD management.
authors.forename: Anne-Laure
authors.initials: AL
authors.lastname: Nevers
authors.forename: Maud
authors.initials: M
authors.lastname: Jandot
authors.forename: Nicolas
authors.initials: N
authors.lastname: Maillot
authors.forename: Yves
authors.initials: Y
authors.lastname: Cottin
mesh_terms: D002317:Cardiovascular Agents / Q000145:classification / Q000627:therapeutic use; D003324:Coronary Artery Disease / Q000145:classification / Q000178:diet therapy / Q000188:drug therapy*; D004032:Diet; D011307:Drug Prescriptions; D006801:Humans; D006920:Hygiene; D017202:Myocardial Ischemia / Q000188:drug therapy; D011379:Prognosis
chemical_list: D002317:Cardiovascular Agents